Backed by Terumo BCT's comprehensive support services
Better for donors
25-40% shorter procedure times than comparable apheresis devices
Single-needle procedures for a more comfortable donation experience
Terumo Penpol personifies the story of a home grown R&D initiative commercialized successfully. Practicing the concept of " Quality First " approach in manufacturing, Terumo Penpol has been serving Blood Centers across the globe for more than thirty years. Partnering with Terumo Corporation, Japan, a global leader in healthcare products, has enabled Terumo Penpol to harness the combined strengths in Technology and Manufacturing to continue redefining standards in Blood Transfusion.With Terumo's recent acquisition of CaridianBCT, Terumo has become the world leader in Blood Management. The Blood Transfusion division of Terumo is being re-organized under the newly acquired company which has been renamed as TerumoBCT. The Apheresis and Cellular Therapy products of Terumo BCT complements Terumo Penpol products to provide a full range of blood collection, storage and processing solutions for Hospitals and Blood Centres in India and other countries.